Amneal Pharmaceuticals Of New York, LLC FDA Inspection Record

FEI 2434153 · Inspections, Form 483s, warning letters and import refusals

Amneal Pharmaceuticals Of New York, LLC is an FDA-registered facility (FEI 2434153) located in Hauppauge, NY, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 11 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Feb 3, 2020: No Action Indicated (NAI)
Inspections on record
11 (7 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
4, latest Aug 17, 2013
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 11 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 3, 2020No Action Indicated (NAI)No citations listed
Mar 18, 2019Voluntary Action Indicated (VAI)Storage under appropriate conditions (21 CFR 211.142(b))
Apr 11, 2017Voluntary Action Indicated (VAI)Clothing appropriate for duties performed (21 CFR 211.28(a))
Aug 9, 2016Voluntary Action Indicated (VAI)Late submission of quarterly safety reports (21 CFR 314.80(c)(2))
Late submission of annual safety reports (21 CFR 314.80(c)(2))
Timely submission (21 CFR 314.81(b)(2))
Mar 16, 2015No Action Indicated (NAI)No citations listed
Feb 7, 2014Voluntary Action Indicated (VAI)No citations listed
May 15, 2012Voluntary Action Indicated (VAI)Complaint Handling Procedure (21 CFR 211.198(a))
Oct 29, 2010No Action Indicated (NAI)No citations listed
May 26, 2010No Action Indicated (NAI)No citations listed
Nov 24, 2009Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Aug 17, 2013Class IID-66014-001Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal…
Failed dissolution specifications; 18 month CRT
Nov 30, 2009Class IID-365-2010Ranitidine Tablets, USP, 150 mg, 500-count bottle, Rx only, Manufactured by: Amneal…
Superpotent (Single Ingredient) Drug: This product is being recalled because of two reports of oversized Ranitidine Tablets. Analysis of a…
Aug 10, 2009Class IID-1973-2009Naproxen Tablets, USP, 500 mg tablets, 1000 tablets per bottle, Rx only -- Manufactured…
Superpotent (Single Ingredient Drug), Tablet Thickness: Amneal Pharmaceuticals has received a report of one oversized (thick) tablet of…
Mar 29, 2007Class IIID-820-2007Ibuprofen Tablets, USP, 200 mg (White Caplets), bulk, NET WEIGHT: 17.00 Kg, NDC…
Failed USP requirement for impurity.

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 18, 20196 x 0.251.5
Inspection classified VAIApr 11, 20176 x 0.251.5
Inspection classified VAIAug 9, 201610 years or older, so it adds no points0
Inspection classified VAIFeb 7, 201410 years or older, so it adds no points0
Class II recall D-66014-001, this FEI as the recalling firmAug 17, 201310 years or older, so it adds no points0
Inspection classified VAIMay 15, 201210 years or older, so it adds no points0
Class II recall D-365-2010, this FEI as the recalling firmNov 30, 200910 years or older, so it adds no points0
Inspection classified VAINov 24, 200910 years or older, so it adds no points0
Inspection classified VAIAug 18, 200910 years or older, so it adds no points0
Class II recall D-1973-2009, this FEI as the recalling firmAug 10, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Amneal Pharmaceuticals Of New York, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Amneal Pharmaceuticals Of New York, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Amneal Pharmaceuticals Of New York, LLC
Location
Hauppauge, NY (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.